Stockreport

Immunovant GAAP EPS of -$0.61 beats by $0.10 [Seeking Alpha]

Immunovant, Inc.  (IMVT) 
PDF As of December 31, 2025, Immunovant's cash and cash equivalents totaled $994.5 million, providing runway for announced indications through the potential commercial laun [Read more]